Events and Meetings already held
Stakeholders’ Consultation Meeting
Date: 8 – 10 July 2015
Venue: World Council of Churches Geneva
Given the impending closure of African Programme for Onchocerciasis Control (APOC) and the increased commitment and momentum to control and eliminate the five neglected tropical diseases (NTDs) amenable to preventive chemotherapy (PC), several discussions have been held between WHO, partners, and endemic countries on establishing a new regional NTD entity to oversee and support accelerated efforts to control and eliminate the five PC NTDs, namely Lymphatic Filariasis, Onchocerciasis, Schistosomiasis, Soil Transmitted Helminthiasis and Trachoma.
Meeting of the 18th WHO Pesticide Evaluation Scheme (WHOPES) Working Group
Dates: 29–30 June & 1 July 2015
Venue: WHO/HQ Geneva
Results of four long-lasting insecticide nets (LLIN) products and their safety assessments will be reviewed. These results will be published in the 18th WHOPES Working Group report on the WHOPES website.
5th Coordination Meeting of HAT activities in the Democratic Republic of the Congo
Date: 16 June 2015
Venue: WHO Geneva – Room D46025
The meeting will discuss how to coordinate current and future financial and/or logistical support for HAT control and surveillance to national programme by international partners.
WHO network for HAT elimination: 3rd meeting of the sub-group “Integration of new tools into national and global policies”
Date: 15 June 2015
Venue: WHO Geneva – Room M105
Alternative approaches and steps will be discussed to introduce fexinidazole - a potential new medicine for the treatment of HAT - in an adequate and coherent manner.
Informal meeting on risk assessment of microbial products for vector control
Dates: 28–29 May 2015
Venue: : WHO/HQ Geneva
Risk assessment is an essential component of vector control product evaluation for new tools. Industry has submitted some new microbial products for evaluation by VCAG but the available risk assessment models do not cover this category of product. This informal meeting will discuss and determine data necessary to evaluate the risk of microbial-based vector control tools, such as Bti products and Wolbachia-infected mosquitoes.
Informal meeting with Ministers of Health of guinea-worm affected countries
Date: 20 May 2015
Venue: Room XII, Palais des Nations, Geneva, Switzerland
The purpose is to secure sustained commitment of all Ministers of Health in accelerating progress to achieve guinea-worm disease transmission by the end of 2015.
Sixty-eighth World Health Assembly
Date: 18–26 May 2015
Venue: World Health Organization Headquarters and Palais of the United Nations, Geneva, Switzerland
The World Health Assembly is the decision-making body of WHO. It is attended by delegations from all WHO Member States and focuses on a specific health agenda prepared by the Executive Board. This year’s agenda includes: WHO reform; Dengue prevention and control; Maternal, infant and young child nutrition; Ending childhood obesity;Prevention and control of noncommunicable diseases; Global burden of epilepsy; Adolescent health;2014 Ebola virus disease outbreak; Monitoring of the achievement of the UN Millennium Development Goals and Health in the post-2015 development agenda. On Monday, 18 May 2015, the German Chancellor. Angela Merkel will address the plenary session at the Palais des Nations.
WHO network for HAT elimination: 2nd meeting of the sub-group “Integration of new tools into national and global policies”
Date: 15 May 2015
Venue: WHO Geneva – Room M505
The meeting will discuss appropriate approaches for the implementation of new diagnostic tools and gaps in elimination strategy.
19th Annual Meeting WHO’s Alliance for the Global Elimination of Blinding Trachoma by 2020 (GET2020)
Date: 27–29 April 2015
Venue: Hammamet, Tunisia
The meeting will discuss progress towards achieving global elimination of trachoma. Participants will also share information and experience on the implementation of the SAFE strategy and discuss obstacles and barriers towards eliminating of trachoma as a public health problem by the year 2020.
Eighth meeting of the Strategic and Technical Advisory Group for Neglected Tropical Diseases
Date: 21–22 April 2015 | Geneva
Venue: WHO/HQ Salle D
This year’s agenda features progress in achieving Roadmap targets and increased domestic investments targets as developed in the latest WHO report on neglected tropical diseases.
Production of a handbook on vector surveillance and control at ports, airports and ground crossings
Date: 24–26 March 2015
Venue: WHO HQ, Room M405, Geneva, Switzerland
Participants will review contents of a handbook on vector surveillance and control at ports, airports and ground crossings. This handbook aims at assisting public health authorities at Points of Entry in strengthening core capacities and to manage vector surveillance and control programmes.
Meeting on control of Buruli ulcer
Date: 23–25 March 2015
Venue: Executive Board Room, WHO Headquarters, Geneva, Switzerland
The meeting will review the epidemiological situation in countries where Buruli ulcer is occurring. Around 150 participants attending this year’s meeting will share information activities relating to Buruli ulcer control, research and evaluate achievements. The meeting will also discuss current coordination of control strategy and will look at control and research priorities for the next two years.
Coordination meeting - National focal points for human African trypanosomiasis
Date: 10–13 March 2015
Venue: Yaoundé, Cameroon
Participants will review disease epidemiology and analyse implementation plans for 2015. Coordination of WHO support to countries will be evaluated and the implementation of an integrated surveillance system discussed.
Consultative bi-regional meeting on visceral leishmaniasis (VL) control strategies and epidemiological situations in East Africa
Date: 24–26 February 2015
Venue: Addis Ababa, Ethiopia
Discussions will include progress and challenges for implementation of VL control strategies in WHO’s NTD roadmap context. The meeting will also look at the AmBisome donation programme implementation and assess needs for coming years.
Global launch of the Third WHO Report on Neglected Tropical Diseases
Date: 19 February 2015 – Time: 15:00 GMT
Venue: A simultaneous launch of the Report, Investing to overcome the global impact of neglected tropical diseases will take place at The Royal Society, London, United Kingdom United Nations Conference Centre, Addis Ababa
This third report analyses for the first time the investments needed to achieve the targets of the WHO Roadmap and universal coverage against NTDs by 2030.It stresses that countries must make firm and sustainable budgetary commitments to address social and health inequities in a fast changing landscape. It argues that existing strategies need to conform to gradual changes taking place at global level and the overall development in emerging economies.
Kala azar elimination programme Partner’s Meeting
Date: 10–11 February 2015
Venue: WHO-HQ Salle D, Geneva, Switzerland
Participants will review progress and challenges regarding implementation of kala azar elimination in the WHO South-east Asia region. A review of specific activities, contribution and engagement of partners to favour a harmonized and coordinated implementation of interventions will also be conducted.
10th Meeting of the International Commission for the Certification of Dracunculiasis Eradication (ICCDE)
Date: 14–15 January 2015
Venue: Room: M 105, WHO HQ, Geneva
The commission will examine Ghana’s claim of achieving dracunculiasis free status and recommend to the Director-General whether it can be certified free of dracunculiasis. Since its establishment in 1995 until December 2013, the ICCDE has recommended to WHO the certification of 197 countries, territories and areas (belonging to 185 Member States).
Scientific Expert Group Meeting on Guinea Worm eradication
Venue: WHO HQ, Room 105
Date: 12–15 January 2015
Worms that are morphologically indistinguishable from those found in humans have been discovered in dogs in Chad. Experts will gather to analyse this unusual pattern of transmission and make appropriate recommendations to WHO.